Cancer patients are choosing ivermectin over chemo, and doctors are concerned
Cancer Patients Turning to Ivermectin Over Chemo, Sparking Doctor Concern
Cancer patients are choosing ivermectin over - Many cancer patients are increasingly choosing ivermectin as an alternative to conventional treatments like chemotherapy, a trend that has raised concerns among medical professionals. Ivermectin, originally developed for parasitic infections, is now being explored for its potential in cancer care. While some patients believe it offers a more accessible or effective option, doctors emphasize the need for scientific validation before it can be considered a reliable treatment.
Growing Patient Interest in Ivermectin
A recent study analyzing electronic medical records from 68 million patients found a notable rise in ivermectin prescriptions for cancer treatment. Between January and July 2025, the number of patients receiving the drug increased by more than 100%, with a significant portion being white males in the Southern U.S. This surge in popularity is attributed to anecdotal reports and public figures promoting its use. Ivermectin's accessibility, including over-the-counter availability in several states, has further fueled its adoption among cancer patients.
Some patients are turning to ivermectin as a standalone therapy, while others use it alongside chemotherapy. Ron Duguay, a former NHL player battling Stage 4 colon cancer, publicly endorsed ivermectin, claiming it played a role in his treatment plan. His comments, along with those of Mel Gibson and others, have influenced a growing number of cancer patients to explore ivermectin as a potential option.
Medical Concerns and Experimental Use
Despite its rising use, ivermectin remains unapproved by the FDA for cancer treatment. Medical experts caution that its application in oncology is still experimental, with no established clinical guidelines to support its use. Dr. John Mafi, a UCLA associate professor, noted that "confirmatory clinical trials are essential to prove ivermectin’s efficacy in cancer care." He warned that relying on unproven therapies could lead to misunderstandings about their true impact.
"Patients who claim ivermectin cured their cancer might be overlooking the role of other proven therapies," said Dr. Merry Jennifer Markham, an oncologist. "While enthusiasm is valuable, we need to ensure the treatment is safe and effective through rigorous testing."
The American Cancer Society highlighted that ivermectin’s use in cancer treatment lacks robust scientific backing. While it’s commonly used for parasitic infections, its mechanism for targeting cancer cells is not yet fully understood. This has led to questions about whether patients are making informed decisions or being swayed by anecdotal evidence.
Side Effects and Treatment Risks
Doctors warn that ivermectin can cause serious side effects, particularly when used in high doses. According to the American Cancer Society, these may include seizures, coma, and, in extreme cases, death. Dr. Skyler Johnson from the University of Utah Huntsman Cancer Institute explained that the doses required for cancer treatment could be toxic to humans, potentially leading to complications that outweigh its benefits.
Additionally, some patients report that ivermectin may worsen side effects of chemotherapy, such as nausea and vomiting. Dr. Markham noted that the drug’s interaction with existing treatment protocols is still under investigation. "While ivermectin shows promise, we must understand its full effect before recommending it widely," she added.
Balancing Innovation and Evidence
As ivermectin gains traction, healthcare providers are striving to balance patient autonomy with scientific rigor. Dr. Markham emphasized that "patients are increasingly asking about ivermectin, and I’m grateful for their curiosity." However, she stressed that evidence-based approaches remain crucial for cancer care. "The goal is to ensure they have accurate information to make informed choices."
Researchers continue to study ivermectin’s potential in oncology, but more data is needed to confirm its effectiveness. While some patients see it as a hopeful alternative, doctors urge caution, reminding that cancer treatment requires proven, targeted therapies. The trend of cancer patients opting for ivermectin highlights the intersection of public perception and medical science, with the future of its use depending on further research and validation.